Literature DB >> 6178963

Immunological characterization and structural studies of normal fecal antigen-1 related to carcinoembryonic antigen.

M Kuroki, T Shinoda, T Takayasu, Y Koga, Y Matsuoka.   

Abstract

Normal fecal antigen-1 (NFA-1), which is a carcinoembryonic antigen (CEA)-related glycoprotein with a mol. wt of 20,000-30,000, was purified from normal adult feces by immuno-adsorption, gel filtration and ion exchange chromatography. Highly purified NFA-1 was partially cross-reactive with CEA but antigenically unrelated to nonspecific cross-reacting antigen (NCA) which was also cross-reactive with CEA. NFA-1 also had a unique determinant not present in CEA or other related antigens including NCA. In a solid-phase RIA system, the reactivity of NFA-1 with a specific anti-CEA antiserum was much stronger than that of NCA. Although digestion with Pronase E did not affect the antigenicity of NFA-1, reduction and alkylation destroyed its antigenic reactivity. The total amount of carbohydrate in NFA-1 was 13.3%, compared to 52.4% in CEA and 21.6% in NCA. The amino acid composition of NFA-1 was similar to that of CEA. The sequence of the first 10 NH2-terminal amino acids in NFA-1 was Ala-Glu-Pro-Pro-Lys-Pro-Phe-Ile-(Thr)-Ser. This was totally different from that of the first NH2-terminal amino acids of CEA isolated from tumor tissue.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178963     DOI: 10.1016/0161-5890(82)90205-x

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  2 in total

1.  Isolation and characterization of cDNA clones encoding the human carcinoembryonic antigen reveal a highly conserved repeating structure.

Authors:  W Zimmermann; B Ortlieb; R Friedrich; S von Kleist
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

2.  Detection of increased fecal carcinoembryonic antigen and its characterization as a membrane-bound form in colorectal carcinoma and other gastrointestinal disorders.

Authors:  K Sugano; H Ohkura; S Hirohashi; Y Shimosato; Y Sakurai; S Kodaira; O Abe
Journal:  Jpn J Cancer Res       Date:  1989-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.